2017 Q4 Form 10-K Financial Statement
#000156459018004757 Filed on March 07, 2018
Income Statement
Concept | 2017 Q4 | 2017 | 2016 Q4 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.390M | $5.330M | $1.090M |
YoY Change | 27.52% | 9.9% | -22.14% |
% of Gross Profit | |||
Research & Development | $3.030M | $13.74M | $2.650M |
YoY Change | 14.34% | 52.67% | -17.7% |
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $4.430M | $19.07M | $3.740M |
YoY Change | 18.45% | 37.72% | -19.05% |
Operating Profit | |||
YoY Change | |||
Interest Expense | -$290.0K | $1.271K | -$530.0K |
YoY Change | -45.28% | -105.8% | 112.0% |
% of Operating Profit | |||
Other Income/Expense, Net | $630.0K | -$1.508M | $620.0K |
YoY Change | 1.61% | 70.48% | -381.82% |
Pretax Income | -$4.080M | -$20.58M | -$3.640M |
YoY Change | 12.09% | 39.71% | -28.49% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$4.080M | -$20.58M | -$3.640M |
YoY Change | 12.09% | 39.68% | -28.49% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$136.4K | -$792.1K | -$182.4K |
COMMON SHARES | |||
Basic Shares Outstanding | 20.17M | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2017 Q4 | 2017 | 2016 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $20.58M | $20.60M | $13.20M |
YoY Change | 55.87% | 56.06% | -6.38% |
Cash & Equivalents | $8.988M | $3.076M | |
Short-Term Investments | $11.59M | $11.60M | $10.10M |
Other Short-Term Assets | $1.300M | $1.300M | $800.0K |
YoY Change | 62.5% | 62.5% | -27.27% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $21.85M | $21.90M | $13.97M |
YoY Change | 56.36% | 56.43% | -8.07% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $300.0K | $300.0K | $600.0K |
YoY Change | -50.0% | -50.0% | 200.0% |
Total Long-Term Assets | $270.0K | $200.0K | $560.9K |
YoY Change | -51.86% | -60.0% | 136.2% |
TOTAL ASSETS | |||
Total Short-Term Assets | $21.85M | $21.90M | $13.97M |
Total Long-Term Assets | $270.0K | $200.0K | $560.9K |
Total Assets | $22.12M | $22.10M | $14.54M |
YoY Change | 52.18% | 52.41% | -5.85% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.529M | $1.500M | $1.204M |
YoY Change | 27.01% | 25.0% | 103.22% |
Accrued Expenses | $2.300M | $2.300M | $1.300M |
YoY Change | 76.92% | 76.92% | -7.14% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $3.500M | $3.500M | $3.300M |
YoY Change | 6.06% | 6.06% | |
Total Short-Term Liabilities | $8.657M | $8.700M | $6.477M |
YoY Change | 33.67% | 33.85% | 227.63% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Total Long-Term Liabilities | $0.00 | $0.00 | $16.31K |
YoY Change | -100.0% | -99.66% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $8.657M | $8.700M | $6.477M |
Total Long-Term Liabilities | $0.00 | $0.00 | $16.31K |
Total Liabilities | $8.657M | $8.700M | $6.493M |
YoY Change | 33.33% | 33.85% | -3.3% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$80.86M | -$60.28M | |
YoY Change | 34.14% | 32.35% | |
Common Stock | $94.34M | $68.33M | |
YoY Change | 38.07% | 25.88% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $13.46M | $13.50M | $8.043M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $22.12M | $22.10M | $14.54M |
YoY Change | 52.18% | 52.41% | -5.85% |
Cashflow Statement
Concept | 2017 Q4 | 2017 | 2016 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$4.080M | -$20.58M | -$3.640M |
YoY Change | 12.09% | 39.68% | -28.49% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$3.950M | -$14.76M | -$2.460M |
YoY Change | 60.57% | 33.32% | -25.45% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$4.400M | -$1.730M | $1.450M |
YoY Change | -403.45% | -157.1% | -26.02% |
Cash From Investing Activities | -$4.400M | -$1.730M | $1.450M |
YoY Change | -403.45% | -157.1% | -26.02% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $22.35M | ||
YoY Change | -293.55% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 14.76M | 22.40M | 1.040M |
YoY Change | 1319.23% | 116.43% | -3566.67% |
NET CHANGE | |||
Cash From Operating Activities | -3.950M | -14.76M | -2.460M |
Cash From Investing Activities | -4.400M | -1.730M | 1.450M |
Cash From Financing Activities | 14.76M | 22.40M | 1.040M |
Net Change In Cash | 6.410M | 5.912M | 30.00K |
YoY Change | 21266.67% | 155.93% | -102.19% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$3.950M | -$14.76M | -$2.460M |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017Q4 | vktx |
Debt Conversion Feature Liability Current
DebtConversionFeatureLiabilityCurrent
|
1397597 | |
CY2016Q4 | vktx |
Debt Conversion Feature Liability Current
DebtConversionFeatureLiabilityCurrent
|
731048 | |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8656575 | |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6476534 | |
CY2016Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
16307 | |
CY2016Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
16307 | |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
8656575 | |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
6492841 | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2016Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3269582 | |
CY2018Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
50898802 | |
CY2017Q2 | dei |
Entity Public Float
EntityPublicFloat
|
21405993 | |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8988478 | |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3075502 | |
CY2017Q4 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
11587478 | |
CY2016Q4 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
10075058 | |
CY2017Q4 | vktx |
Prepaid Clinical Trial Costs
PrepaidClinicalTrialCosts
|
886873 | |
CY2016Q4 | vktx |
Prepaid Clinical Trial Costs
PrepaidClinicalTrialCosts
|
541603 | |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
388969 | |
CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
282666 | |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
21851798 | |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13974829 | |
CY2017Q4 | vktx |
Deferred Public Offering And Other Financing Costs Noncurrent
DeferredPublicOfferingAndOtherFinancingCostsNoncurrent
|
269613 | |
CY2016Q4 | vktx |
Deferred Public Offering And Other Financing Costs Noncurrent
DeferredPublicOfferingAndOtherFinancingCostsNoncurrent
|
521538 | |
CY2016Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
39341 | |
CY2017Q4 | us-gaap |
Assets
Assets
|
22121411 | |
CY2016Q4 | us-gaap |
Assets
Assets
|
14535708 | |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1529935 | |
CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1203888 | |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2256543 | |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1237122 | |
CY2017Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
21960 | |
CY2016Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
34894 | |
CY2017Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3450540 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
169398 | |
CY2017 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-12877 | |
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
358 | |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
208 | |
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
94339179 | |
CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
68326818 | |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-80854932 | |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-60277267 | |
CY2017Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-19769 | |
CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-6892 | |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13464836 | |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8042867 | |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
22121411 | |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14535708 | |
CY2017Q4 | vktx |
Convertible Notes Payable Discount Current
ConvertibleNotesPayableDiscountCurrent
|
404437 | |
CY2016Q4 | vktx |
Convertible Notes Payable Discount Current
ConvertibleNotesPayableDiscountCurrent
|
675589 | |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
35817104 | |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20823873 | |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
35817104 | |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20823873 | |
CY2017 | us-gaap |
Revenues
Revenues
|
0 | |
CY2016 | us-gaap |
Revenues
Revenues
|
0 | |
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13741186 | |
CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
9000499 | |
CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5329003 | |
CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4846776 | |
CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
19070189 | |
CY2016 | us-gaap |
Operating Expenses
OperatingExpenses
|
13847275 | |
CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13847275 | |
CY2017 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1282631 | |
CY2017 | vktx |
Amortization Of Financing Costs Equity Transactions
AmortizationOfFinancingCostsEquityTransactions
|
571044 | |
CY2016 | vktx |
Amortization Of Financing Costs Equity Transactions
AmortizationOfFinancingCostsEquityTransactions
|
138701 | |
CY2017 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
1271 | |
CY2016 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-21928 | |
CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1507476 | |
CY2016 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-884547 | |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20577665 | |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14731822 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-1729707 | |
CY2016 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
478 | |
CY2017 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-20590542 | |
CY2016 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-14731344 | |
CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.79 | |
CY2016 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.90 | |
CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
25978098 | |
CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
16278292 | |
CY2015Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
8724998 | |
CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
1785326 | |
CY2016 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1200000 | |
CY2016 | vktx |
Stock Issued During Period Value Sale Of Stock Net Of Issuance Costs
StockIssuedDuringPeriodValueSaleOfStockNetOfIssuanceCosts
|
11063887 | |
CY2016Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
8042867 | |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
1429753 | |
CY2017 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
73141 | |
CY2016 | us-gaap |
Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
|
153735 | |
CY2016 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-40659 | |
CY2016 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
677185 | |
CY2016 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-141295 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-14757767 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-11071263 | |
CY2016 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
16922235 | |
CY2016 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
19952000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
3029765 | |
CY2016 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
11548518 | |
CY2016 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1096205 | |
CY2016 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
229 | |
CY2017 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
77261 | |
CY2016 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
94861 | |
CY2017 | vktx |
Proceeds From Stock Issuance Under Employee Stock Purchase Plan And Warrant Exercises
ProceedsFromStockIssuanceUnderEmployeeStockPurchasePlanAndWarrantExercises
|
647790 | |
CY2016 | vktx |
Proceeds From Stock Issuance Under Employee Stock Purchase Plan And Warrant Exercises
ProceedsFromStockIssuanceUnderEmployeeStockPurchasePlanAndWarrantExercises
|
22288 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
22400450 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
10348450 | |
CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
5912976 | |
CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2306952 | |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
768550 | |
CY2017 | us-gaap |
Interest Paid
InterestPaid
|
122739 | |
CY2016 | us-gaap |
Interest Paid
InterestPaid
|
205139 | |
CY2017 | us-gaap |
Stock Issued1
StockIssued1
|
1800000 | |
CY2017 | vktx |
Unpaid Deferred Initial Public Offering And Other Financing Costs
UnpaidDeferredInitialPublicOfferingAndOtherFinancingCosts
|
139585 | |
CY2017 | vktx |
Receivable From Exercise Of Warrants
ReceivableFromExerciseOfWarrants
|
103802 | |
CY2016 | vktx |
Repayments Of Notes Payable In Stock
RepaymentsOfNotesPayableInStock
|
1200000 | |
CY2017 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications have been made to certain of the prior years’ financial statements to conform to the current year presentation.</p></div> | |
CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements relate to determining the fair value of the debt conversion feature liability and accounting for certain commitments. Actual results could differ from those estimates.</p></div> | |
CY2017 | dei |
Entity Incorporation State Country Name
EntityIncorporationStateCountryName
|
Delaware | |
CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to concentration of credit risk, consist primarily of cash and cash equivalents and marketable securities. The Company maintains deposits in federally insured depository institutions in excess of federally insured limits. Management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. Additionally, the Company has established guidelines regarding approved investments and maturities of investments, which are designed to maintain safety and liquidity.</p></div> | |
CY2017 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2012-09-24 | |
CY2016 | vktx |
Debt Instrument Current Maturities Due Date
DebtInstrumentCurrentMaturitiesDueDate
|
2016 | |
CY2016Q1 | vktx |
Debt Instrument Current Maturities Due Date
DebtInstrumentCurrentMaturitiesDueDate
|
2017 | |
CY2017Q2 | vktx |
Debt Instrument Current Maturity Date
DebtInstrumentCurrentMaturityDate
|
2018-05-21 | |
CY2016Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
7754286 | |
CY2016Q2 | vktx |
Underwriting Discounts Commissions And Other Offering Expenses
UnderwritingDiscountsCommissionsAndOtherOfferingExpenses
|
1631964 | |
CY2014Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
|
1000000 | |
CY2014Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Exercise Price
DeferredCompensationArrangementWithIndividualExercisePrice
|
0.01 | |
CY2016Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.50 | |
CY2016Q2 | vktx |
Additional Shares Offered Under Underwriting Agreement
AdditionalSharesOfferedUnderUnderwritingAgreement
|
1125000 | |
CY2016Q2 | vktx |
Underwriters Grant Period Option
UnderwritersGrantPeriodOption
|
P45D | |
CY2016Q2 | vktx |
Additional Warrants Granted To Underwriters
AdditionalWarrantsGrantedToUnderwriters
|
1125000 | |
CY2016Q2 | vktx |
Additional Warrants Sold As Result Of Over Allotment Exercise
AdditionalWarrantsSoldAsResultOfOverAllotmentExercise
|
1125000 | |
CY2017 | us-gaap |
Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
|
Three months or less | |
CY2017Q4 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
5900000 | |
CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14187019 | |
CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14458811 | |
CY2017 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
CY2017 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
0 | |
CY2016 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
0 | |
CY2017Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
11606475 | |
CY2017Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
18997 | |
CY2017Q4 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
29 | |
CY2016Q4 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
25 | |
CY2017Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
19192378 | |
CY2017Q4 | vktx |
Debt Conversion Feature Liability Noncurrent
DebtConversionFeatureLiabilityNoncurrent
|
1397597 | |
CY2017Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
1397597 | |
CY2016Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
12594380 | |
CY2016Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
731048 | |
CY2017 | vktx |
License Agreement Entered Date
LicenseAgreementEnteredDate
|
2014-05 | |
CY2017 | vktx |
Date Of Registration Rights Agreement Amendment
DateOfRegistrationRightsAgreementAmendment
|
2016-01-22 | |
CY2017Q4 | vktx |
Convertible Notes Payoff Value Current
ConvertibleNotesPayoffValueCurrent
|
1938469 | |
CY2016Q4 | vktx |
Convertible Notes Payoff Value Current
ConvertibleNotesPayoffValueCurrent
|
1990032 | |
CY2016 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.05 | |
CY2016Q1 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.025 | |
CY2014Q1 | vktx |
Number Of Tranches
NumberOfTranches
|
2 | |
CY2014Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
168000 | |
CY2015Q2 | us-gaap |
Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
|
633810 | |
CY2015Q2 | vktx |
Shares Repurchase Price Per Share
SharesRepurchasePricePerShare
|
0.00001 | |
CY2015Q2 | us-gaap |
Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
|
366190 | |
CY2015Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
61556 | |
CY2016Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
7500000 | |
CY2016Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
1.25 | |
CY2016Q2 | us-gaap |
Share Price
SharePrice
|
0.01 | |
CY2017 | vktx |
Class Of Warrants Or Rights Expiry Date
ClassOfWarrantsOrRightsExpiryDate
|
2021-04-13 | |
CY2016Q2 | vktx |
Over Allotment Option Exercised
OverAllotmentOptionExercised
|
1125000 | |
CY2016Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
1125000 | |
CY2016Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1283400 | |
CY2016Q2 | vktx |
Underwriting Discounts Commissions And Other Offering Expenses
UnderwritingDiscountsCommissionsAndOtherOfferingExpenses
|
111600 | |
CY2016 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
21616 | |
CY2017 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
42823 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
365394 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
620818 | |
CY2016 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-4029121 | |
CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-2060635 | |
CY2016 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-364340 | |
CY2017 | us-gaap |
Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
|
-8199433 | |
CY2016 | us-gaap |
Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
|
-4393461 | |
CY2017 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
9539678 | |
CY2017 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-1340245 | |
CY2016 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
4393461 | |
CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
102375 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
883837 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
892534 | |
CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
22030 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
178477 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
587164 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
8.48 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.01 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.55 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.28 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.25 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.39 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
3.55 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.68 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
4.19 | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y10M13D | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
693644 | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1057749 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.89 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.40 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.851 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.826 | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y10M28D | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y10M24D | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0197 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0159 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2017 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
0 | |
CY2017Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
15305009 | |
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
10.00 | |
CY2017 | vktx |
Description Of Warrant
DescriptionOfWarrant
|
The warrant is exercisable for cash or on a cashless basis at a per share exercise price equal to $10.00 commencing on April 28, 2016, one year following the date of the prospectus filed with the SEC relating to the IPO, and expiring on April 28, 2020. In addition, the warrant provides for registration rights upon request, under certain circumstances. The piggyback registration right provided in connection with the warrant will terminate on April 28, 2022. | |
CY2017 | vktx |
Warrant Expiration Date
WarrantExpirationDate
|
2022-04-28 | |
CY2017 | vktx |
Initial Public Offering Expiration Date
InitialPublicOfferingExpirationDate
|
2020-04-28 | |
CY2017Q1 | vktx |
Common Stock Issuable Upon Exercise Of Warrant
CommonStockIssuableUponExerciseOfWarrant
|
82500 | |
CY2016 | vktx |
Class Of Warrants Or Rights Expiry Date
ClassOfWarrantsOrRightsExpiryDate
|
2021-04-13 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
8172699 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
452301 | |
CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
CY2016 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | |
CY2016 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
0 | |
CY2016 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-6138798 | |
CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.10 | |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.03 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.04 | |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.07 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.01 | |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.00 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.46 | |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.00 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.07 | |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.30 | |
CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.00 | |
CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.00 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
53032 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
59333 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
14696888 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
16388591 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4948795 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4558964 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1030457 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1289957 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
265588 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
6679 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
3017 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
21001439 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
22299862 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
20775747 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
22115992 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
225692 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
183870 | |
CY2017Q4 | vktx |
Deferred Tax Liabilities Convertible Debt
DeferredTaxLiabilitiesConvertibleDebt
|
225692 | |
CY2016Q4 | vktx |
Deferred Tax Liabilities Convertible Debt
DeferredTaxLiabilitiesConvertibleDebt
|
183870 | |
CY2017Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
225692 | |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
183870 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | |
CY2017 | vktx |
Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Assets
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssets
|
-9645000 | |
CY2017 | vktx |
Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Liability
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxLiability
|
-105000 | |
CY2017 | vktx |
Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Valuation Allowance
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxValuationAllowance
|
-9540000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
17773000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
17419000 | |
CY2017 | vktx |
Federal And State Net Operating Loss Carryforwards Begin To Expiration Year
FederalAndStateNetOperatingLossCarryforwardsBeginToExpirationYear
|
2032 | |
CY2017 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
Specifically, this limitation may arise in the event of an “ownership change,” which is defined by Section 382 of the Code as a cumulative change in ownership of the Company of more than 50% within a three-year period. If the Company undergoes one or more ownership changes in connection with any future transactions in its stock, the Company’s ability to utilize net operating loss carryforwards to offset federal taxable income, if any, could potentially result in increased future tax liability to the Company. An ownership change under Section 382 of the Code occurred during the year ended December 31, 2015 in connection with the Company’s initial public offering. However, the Company is able to utilize all of its net operating losses. The Company conducted a further assessment of ownership changes and determined that, through December 31, 2017, there have not been any additional ownership changes in accordance with Section 382 of the Code. | |
CY2017 | vktx |
Percentage Of Cumulative Change In Stock Ownership
PercentageOfCumulativeChangeInStockOwnership
|
0.50 | |
CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2016Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2017Q4 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
0 | |
CY2016Q4 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
0 | |
CY2017 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
249057 | |
CY2016 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
253316 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
169398 |